Phenylephrine Hydrochloride Injection

[30 September 2014]

Products Affected - Description

Phenylephrine hydrochloride 10 mg/mL - American Regent
1 mL vials (NDC 00517-0299-25)
5 mL vials (NDC 00517-0405-25)

Reason for the Shortage

  • American Regent has phenylephrine injection on shortage due to increased demand for the product.
  • Sandoz could not provide a reason for the phenylephrine injection shortage.

Available Products

Phenylephrine hydrochloride 10 mg/mL – Sandoz
5 mL vials (NDC 66758-0016-04)
10 mL vials (NDC 66758-0017-01)
Phenylephrine hydrochloride 10 mg/mL – West-Ward
1 mL vials, 25 count (NDC 00641-6142-25)

Estimated Resupply Dates

  • American Regent has phenylephrine 10 mg/mL 1 mL and 5 mL vials on back order and the company cannot estimate a release date.
  • Sandoz and West-Ward have consistently supplied the market for several months.

Related Shortages


September 30, 2014; July 29, 2014; June 30, 2014; June 19, 2014; May 1, 2014; April 16, 2014; March 27, 2014; March 5, 2014; January 24, 2014; January 14, 2014; January 3, 2014; December 12, 2013; October 7, 2013; August 26, 2013; July 16, 2013; April 29, 2013; March 26, 2013; February 20, 2013; February 11, 2013 University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing